Best Life Sciences Platforms and Tools Companies in Stockholm County, Sweden
The 38 best Life Sciences Platforms and Tools companies in Stockholm County, Sweden in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ITBMed.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Stockholm County
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ITBMed Developer of monoclonal antibodies to prevent transplant rejections | $87M | 57 mo ago | 28 | David Sachs Co-Founder | WordPressApple iCloud MailMicrosoft 365+20 | Top 50M | — | — |
| 2 | EnginZyme Developer of immobilized enzymes | $35M | 44 mo ago | 59 | Samuel Hargestam Co-Founder | — | — | 48 patents Enzymatic biocatalysis for nucleoside analog production and organic synthesis. | — |
| 3 | Cellectricon Assay development for drug discovery services | $27M | 92 mo ago | 20 | — | WordPressMySQLPHP+23 | Top 50M | 74 patents High‑density microplate platforms for compartmentalized cell culture and assay automation | — |
| 4 | BioLamina Cell culture reagents for stem cell research | $18M | 4 mo ago | 75 | Magnus Kenneby Co-Founder | WordPress Block EditorCart FunctionalityWordPress+28 | Top 5M | 134 patents Stem cell differentiation methods for retinal pigment epithelium and dopaminergic neuron production | — |
| 5 | Devyser Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15M | 67 mo ago | 106 | — | DrupalApple iCloud MailMicrosoft 365+27 | Top 5M | — | — |
| 6 | Dilafor Pharmaceutical company developing heparin derivatives with low anticoagulant activity | $8M | 88 mo ago | 4 | Lena Degling Wikingsson CEO | — | — | 138 patents Heparin-derived anticoagulant therapy for preeclampsia treatment | — |
| 7 | Single Technologies Developer of a technology platform for single-molecule imaging | $8M | 30 mo ago | 24 | — | — | — | — | — |
| 8 | Symcel Microcalorimeter for cell metabolism measurements | $6M | 105 mo ago | 32 | Jesper Ericsson CEO | HubSpot CMS HubHubSpotFancyBox+16 | Top 10M | 12 patents Rapid calorimetric antimicrobial susceptibility testing for clinical microbiology diagnostics. | 2 launchs |
| 9 | Pixelgen Technolgies Developer of ground-breaking technologies for biomedical research and diagnostics | $6M | 35 mo ago | 23 | Filip Karlsson Co-Founder | WordPressMySQLPHP+16 | Top 10M | — | — |
| 10 | Epigenica Provider of solutions for the analysis of genomic data | $2M | 14 mo ago | — | Simon Alsatian Co-Founder | — | — | 14 patents High‑throughput multiplexed epigenomic profiling of cell‑free DNA and chromatin modifications | — |
| 11 | APLEX Bio Limited information available | $2M | 54 mo ago | 12 | Umear Naseem Founder & CEO | Wix eCommerceWixSentry+11 | Top 50M | 16 patents Multiplexed biomolecule detection using PCR, padlock probes, and nanomaterial assays | 1 job opening |
| 12 | BrainZell Developer of lab-grown cell based models of the human brain for drug development | $1M | 24 mo ago | 2 | Robin Pronk Co-Founder | — | — | — | — |
| 13 | BioReperia Develops animal model for oncology and toxicology | $882K | 68 mo ago | 24 | — | — | — | — | — |
| 14 | CARTANA Provider of gene expression mapping technology in brain tissue | $330K | 80 mo ago | 18 | Xiaoyan Qian Co-Founder | — | — | 11 patents Nucleic acid detection and sequencing, focusing on RNA‑templated ligation methods. | — |
Top 12 Life Sciences Platforms and Tools companies in Stockholm County
#1
Series B · Sundbyberg, Stockholm County · founded 2008 · 75 employees$18.2Mraised▾
BioLamina is a biotechnology company that manufactures full-length human recombinant laminins for primary and stem-cell culture applications. The company's product portfolio includes recombinant laminins as cell culture matrices for specific uses like pluripotent stem cell culture, early epithelial development and differentiation, and kits with multiple laminins for screening the most appropriate matrix for specific cell types.
- Apr 2026Conventional Debt$23.6M
- Sep 2023Series B$18.2M
- Apr 2021Grant (prize money)$444.3K
- Aug 2009Grant (prize money)$331.6K
#2
Seed · Stockholm, Stockholm County · founded 2020$2.3Mraised▾
Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.
- Jun 2025Seed$2.2M
- Jul 2022Grant (prize money)$125K
#3
Series A · Stockholm, Stockholm County · founded 2016 · 28 employees$87Mraised▾
Developer of monoclonal antibodies to prevent transplant rejections. The company is developing a humanized IgG1K antibody, Siplizumab which targets human CD2 molecules. The antibody binds to the human CD2 receptor found on T lymphocytes (T cells), natural killer cells, and thymocytes to inhibit their activation. The lead candidate Siplizumab is in the pivotal stage of the clinical trial for solid organ transplantation, and bone marrow transplantation.
- Dec 2021Series A$20M
- Apr 2018Angel$67M
#4
Series B · Stockholm, Stockholm County · founded 2014 · 59 employees$34.7Mraised▾
Developer of immobilized enzymes. It employs a patented enzyme immobilization technology that enables the use of enzymes as catalysts in chemical processes. Its core technology allows for productive enzyme usage in various applications, including food, cosmetics, and pharmaceuticals.
- Dec 2022Series B$22.2M
- Feb 2021Series A$5.6M
- Apr 2020Series A$6.9M
- Jan 2020Grant (prize money)$332.2K
#5
Series A · Stockholm, Stockholm County · founded 2012 · 24 employees$7.6Mraised▾
Single Technologies has developed a platform for single-molecule imaging. The company's product includes the Model Theta, a single molecule sensitive confocal microscope that provides 3D video solution based on the photon-counting detector used for single-molecule imaging.
#6
Series A · Stockholm, Stockholm County · founded 2020 · 23 employees$6Mraised▾
Developer of ground-breaking technologies for biomedical research and diagnostics. The company has developed Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins, to gain novel insights into cellular activity to advance better medicines and diagnostics.
- Oct 2023Series A—
- Dec 2022Seed$6M
#7
Seed · Stockholm, Stockholm County · founded 2020 · 2 employees$1.5Mraised▾
Developer of lab-grown cell-based models of the human brain intended to make medicine discovery more effective and minimize the use of animals. The company uses stem cell-based models that match the human brain better than that of animals, enabling patients to have safer pharmaceuticals.
- Aug 2024Seed$1.5M
#8
Series C · Molnbo, Stockholm County · founded 2001 · 20 employees$27.2Mraised▾
Cellectricon focuses on developing assays for drug discovery using their proprietary platform Cellaxess® Elektra. The platform works with localized electric field manipulation and high-speed fluorescence imaging to monitor parameters such as neuronal excitability, synaptic efficacy and synaptic plasticity in primary and stem cell-derived neurons. The therapeutic areas company is targeting are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Schizophrenia, and Chronic pain. The company also plans to use High content screening with PerkinElmer Operetta® system and KNIME data mining software platform to generate comprehensive data.
- Jan 2019Grant (prize money)$323.2K
- Apr 2011Series C$3M
- Feb 2008Series C$12.3M
- Sep 2006Grant (prize money)$317.4K
#9
Public · Stockholm, Stockholm County · founded 2004 · 106 employees$15.5Mraised▾
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders. The company's products include NGS-based kits for the characterization of BRCA 1/2, NGS-based gene panel tests for familial hypercholesterolemia, cystic fibrosis, thrombophilia, hereditary hemochromatosis, APOE characterization for risk of late-onset Alzheimer’s disease, cardiovascular disease, QF-PCR-based tests for prenatal aneuploidy, and a range of cytogenetic defects.
- Feb 2021Series B$15.5M
- Jan 2021Grant (prize money)$905.4K
#10
Series A · Solna, Stockholm County · founded 2003 · 4 employees$8.5Mraised▾
Dilafor is a clinical stage biopharmaceutical company that is working on low anticoagulant heparin (LAH) derivatives for indications where heparin is currently not approved due to its anticoagulant activity. The company has one product, Tafoxiparin, under development for treatment and prevention of protracted labor. Tafoxiparin is similar in activity to Fragmin, which is a low molecular weight heparin and the current standard of care for protracted labor, without the anticoagulative properties. Tafoxiparin has been used and shown to be safe in a total of three clinical trials involving 335 subjects of whom 263 were term pregnant women. The results have been encouraging enough for the company to initiate a clinical development program for Tafoxiparin to be used as an adjuvant therapy for women induced into labor and for women in need of labor augmentation due to labor arrest after spontaneous onset of labor.
- Apr 2019Series A$2.5M
- Sep 2016Series A$6M
#11
Series A · Stockholm, Stockholm County · founded 2004 · 32 employees$6.3Mraised▾
Symcel manufactures instruments for calorimetry analysis (cell-based assays). The company's product flagship CalScreener uses differences in temperature up to one-thousandth of a kelvin to measure the metabolic activity. It also has the CalPlate system, which is a series of consumables to be used with the CalScreener. CalWell, consists of cell culture plates, can be used both with liquid and solid media. The company also provides calView, for data collection and analysis which is included within the instrument.
- Dec 2017Grant (prize money)$4.2M
- Nov 2017Grant (prize money)$4.2M
- Jan 2017Grant (prize money)$3.8M
- Jul 2016Grant (prize money)$55.2K
#12
Seed · Solna, Stockholm County · founded 2020 · 12 employees$1.5Mraised▾
Developer of a hyperplexed molecular detection technology designed for the analysis of numbers of biomarkers both in vitro and in situ. The company's technology utilizes nano and biochemistry to facilitate applications from research to mass-scale in-vitro diagnostics and precision diagnostics, enabling doctors to achieve highly parallelized detection of biomarkers in an easy and cost-efficient way.
- Mar 2022Seed$1.5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Sweden
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 715 Sweden-affiliated papers.
- Karolinska Institutet214
- Science for Life Laboratory88
- Lund University87
- Karolinska University Hospital86
- Uppsala University62
- Transcriptome3→23
- Proteomics2→19
- Gene2→17
- Genome2→15
- Population1→10
- Disease1→33
- Proteomics1→10
- Population1→8
- In silico1→6
- Proteome1→6
- Microbiome1→7
- Immune system1→6
- Transcriptome1→5
- Mechanism (biology)1→5
- Gene1→5
Where bioinformatics is researched across Sweden
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.